These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16132760)

  • 1. Prognostic significance of thymidine phosphorylase in superficial bladder carcinoma.
    Stavropoulos NE; Bouropoulos C; Ioachim E; Michael M; Hastazeris K; Tsimaris I; Kalogeras D; Liamis Z; Kafarakis V; Stefanaki S; Malamou-Mitsi V
    Int Urol Nephrol; 2005; 37(1):55-60. PubMed ID: 16132760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of thymidine phosphorylase is a prognostic predictor for the intravesical recurrence of superficial bladder cancer.
    Nonomura N; Nakai Y; Nakayama M; Inoue H; Nishimura K; Hatanaka E; Arima R; Kishimoto T; Miki T; Kuroda H; Okuyama A
    Int J Clin Oncol; 2006 Aug; 11(4):297-302. PubMed ID: 16937303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymidine phosphorylase expression as a prognostic marker for predicting recurrence in primary superficial bladder cancer.
    Aoki S; Yamada Y; Nakamura K; Taki T; Tobiume M; Honda N
    Oncol Rep; 2006 Aug; 16(2):279-84. PubMed ID: 16820903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of thymidine phosphorylase as an indicator of poor prognosis for patients with transitional cell carcinoma of the bladder.
    Arima J; Imazono Y; Takebayashi Y; Nishiyama K; Shirahama T; Akiba S; Furukawa T; Akiyama S; Ohi Y
    Cancer; 2000 Mar; 88(5):1131-8. PubMed ID: 10699904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in stage pT1 G3 bladder cancer.
    Li S; Nomata K; Sawase K; Noguchi M; Kanda S; Kanetake H
    Int J Urol; 2001 Sep; 8(9):478-82. PubMed ID: 11683966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers.
    O'Brien TS; Fox SB; Dickinson AJ; Turley H; Westwood M; Moghaddam A; Gatter KC; Bicknell R; Harris AL
    Cancer Res; 1996 Oct; 56(20):4799-804. PubMed ID: 8841001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of angiogenesis in superficial bladder cancer.
    Stavropoulos NE; Bouropoulos C; Ioachim IE; Michael M; Hastazeris K; Tsimaris I; Kalogeras D; Liamis Z; Stefanaki S; Agnantis NI
    Int Urol Nephrol; 2004; 36(2):163-7. PubMed ID: 15368686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factors HIF-1alpha and HIF-2alpha expression in bladder cancer and their associations with other angiogenesis-related proteins.
    Ioachim E; Michael M; Salmas M; Michael MM; Stavropoulos NE; Malamou-Mitsi V
    Urol Int; 2006; 77(3):255-63. PubMed ID: 17033215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma.
    Imazano Y; Takebayashi Y; Nishiyama K; Akiba S; Miyadera K; Yamada Y; Akiyama S; Ohi Y
    J Clin Oncol; 1997 Jul; 15(7):2570-8. PubMed ID: 9215827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A diagnostic marker for superficial urothelial bladder carcinoma: lack of nuclear ATBF1 (ZFHX3) by immunohistochemistry suggests malignant progression.
    Kawaguchi M; Hara N; Bilim V; Koike H; Suzuki M; Kim TS; Gao N; Dong Y; Zhang S; Fujinawa Y; Yamamoto O; Ito H; Tomita Y; Naruse Y; Sakamaki A; Ishii Y; Tsuneyama K; Inoue M; Itoh J; Yasuda M; Sakata N; Jung CG; Kanazawa S; Akatsu H; Minato H; Nojima T; Asai K; Miura Y
    BMC Cancer; 2016 Oct; 16(1):805. PubMed ID: 27756245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The significance of platelet-derived endothelial cell growth factor mRNA expression in superficial bladder cancer].
    Li G; Zhang YF; Ding Q; Yan CY; Wen DG
    Zhonghua Wai Ke Za Zhi; 2004 Apr; 42(8):478-81. PubMed ID: 15144643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymidine phoshorylase expression in breast cancer: the prognostic significance and its association with other angiogenesis related proteins and extracellular matrix components.
    Ioachim E
    Histol Histopathol; 2008 Feb; 23(2):187-96. PubMed ID: 17999375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E-cadherin immunoreactivity correlates with recurrence and progression of minimally invasive transitional cell carcinomas of the urinary bladder.
    Mahnken A; Kausch I; Feller AC; Krüger S
    Oncol Rep; 2005 Oct; 14(4):1065-70. PubMed ID: 16142373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 expression compared with other prognostic factors in OMS grade-I stage-Ta transitional cell carcinoma of the bladder.
    Casetta G; Gontero P; Russo R; Pacchioni D; Tizzani A
    Eur Urol; 1997; 32(2):229-36. PubMed ID: 9286659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 standard form expression as a predictor of progression in high risk superficial bladder tumors.
    Stavropoulos NE; Filliadis I; Ioachim E; Michael M; Mermiga E; Hastazeris K; Nseyo UO
    Int Urol Nephrol; 2001; 33(3):479-83. PubMed ID: 12230276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of thymidine phosphorylase in an in vitro model of human bladder cancer invasion.
    Jones A; Fujiyama C; Turner K; Cranston D; Williams K; Stratford I; Bicknell R; Harris AL
    J Urol; 2002 Mar; 167(3):1482-6. PubMed ID: 11832774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymidine phosphorylase and dihydropyrimidine dehydrogenase in bladder cancer.
    Iizumi T; Hariu K; Sato M; Sato S; Shimizu H; Tomomasa H; Umeda T
    Urol Int; 2002; 68(2):122-5. PubMed ID: 11834904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The analysis of thymidine phosphorylase examined by ELISA in bladder cancer].
    Saegusa M; Takao A; Manabe D; Ichikawa T; Aramaki K; Nakayama Y; Yamada D
    Nihon Hinyokika Gakkai Zasshi; 2002 Nov; 93(7):743-9. PubMed ID: 12494519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas.
    Dickinson AJ; Fox SB; Newcomb PV; Persad RA; Sibley GN; Harris AL
    J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.